Complete Filing Data
Quality Industrial Corp. reported Net Income Loss of -$5.44 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Quality Industrial Corp. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$5.4M | -$523.0K | -$4.2M | -$102.9K | -$5.2M | -$2.0M | -$2.9M |
| Revenue * | $16.3M | $11.2M | $65.00 | ||||
| Operating Income Loss | -$456.8K | $698.3K | -$2.8M | -$421.5K | -$5.2M | -$1.9M | -$49.9K |
| Operating Expenses | $5.2M | $3.3M | $2.8M | $421.5K | $5.2M | $1.9M | $94.3K |
| Interest Expense | -$3.8M | -$4.4K | $7.1K | ||||
| Selling General And Administrative Expense | $11.2M | $331.6K | $53.5K | $18.9K | |||
| General And Administrative Expense | $4.9M | $2.3M | $2.5M | $126.8K | |||
| Gross Profit | $4.8M | $4.0M | $21.7M | $44.4K | |||
| Cost Of Revenue | $11.5M | $7.2M | $43.9M | ||||
| Nonoperating Income Expense | -$4.0M | -$275.2K | -$1.5M | ||||
| Interest Expense Nonoperating | $82.4K | $94.7K | $9.0K | ||||
| Research And Development Expense | $4.8M | $6.0K | $2.9K | ||||
| Other Nonoperating Income Expense | $427.6K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.9M | -$2.9M | |||||
| Income Tax Expense Benefit | $165.1K | $156.3K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$264.2K | -$195.9K | -$1.4M | -$497.7K | $97.6K | $206.7K | -$1.9M | -$1.6M | $2.0M | $2.6M | $2.4M | $1.9M | -$170.0K | -$147.3K | -$4.6M | -$222.2K | -$189.8K | -$150.2K | -$1.5M | -$22.0K |
| Revenue * | $3.5M | $4.0M | $3.6M | $2.7M | $3.3M | $3.1M | $22.1M | $21.6M | $18.2M | $28.3M | $19.1M | $18.2M | ||||||||
| Operating Income Loss | -$285.8K | $440.5K | -$947.1K | $85.2K | $426.1K | -$81.2K | -$1.8M | -$835.3K | -$65.0K | $5.5M | $2.9M | $2.0M | -$184.4K | -$146.2K | -$4.6M | -$221.1K | -$188.7K | -$149.3K | -$1.5M | -$22.0K |
| Operating Expenses | $1.5M | $879.6K | $1.9M | $995.6K | $822.4K | $81.2K | $1.8M | $835.3K | $65.0K | $4.1M | $3.8M | $3.4M | $184.4K | $146.2K | $4.6M | $221.1K | $188.7K | $149.3K | $1.5M | $22.0K |
| Interest Expense | -$1.8M | -$1.0M | -$971.4K | -$3.0M | -$1.2M | -$408.8K | $1.0K | -$1.1K | -$1.1K | $1.1K | $1.1K | $813.00 | $5.2K | |||||||
| Selling General And Administrative Expense | $4.1M | $3.8M | $19.7K | $37.5K | $78.0K | $4.5M | $90.0K | $79.4K | $10.9K | $7.2K | $1.2K | |||||||||
| General And Administrative Expense | $1.4M | $824.9K | $1.9M | $751.3K | $750.7K | $32.9K | $1.7M | $753.4K | $34.6K | $3.2M | $3.3M | $37.5K | ||||||||
| Gross Profit | $1.2M | $1.3M | $955.4K | $1.1M | $1.2M | $1.1M | $8.0M | $7.9M | $5.5M | $9.6M | $6.6M | $5.4M | ||||||||
| Cost Of Revenue | $2.3M | $2.7M | $2.7M | $1.6M | $2.1M | $1.9M | $14.1M | $13.7M | $12.7M | $18.6M | $12.5M | $12.8M | ||||||||
| Nonoperating Income Expense | $245.6K | -$283.9K | -$285.4K | -$388.9K | -$54.0K | $287.9K | -$129.3K | -$746.9K | $1.2M | |||||||||||
| Interest Expense Nonoperating | $11.7K | $27.4K | $32.2K | $56.1K | $20.3K | $129.3K | $25.7K | |||||||||||||
| Research And Development Expense | $68.2K | $6.0K | ||||||||||||||||||
| Other Nonoperating Income Expense | $318.7K | $48.0K | $379.6K | $0.00 | -$721.2K | -$19.5K | ||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | ||||||||||||||||||||
| Income Tax Expense Benefit | $38.1K | $57.3K | $27.1K | $36.1K | $43.9K | $0.00 | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$1.7M | $2.0M | $743.5K | -$192.9K | -$369.0K | -$3.0K | $71.7K | $35.2K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $426.6K | $225.6K | $2.5K | $3.1K | $15.7K | $19.6K | ||
| Common Stock Value | $179.1K | $126.6K | $127.1K | $102.9K | $94.7K | $105.0K | $104.4K | |
| Retained Earnings Accumulated Deficit | -$22.7M | -$17.2M | -$16.7M | -$12.5M | -$12.8M | -$7.6M | -$5.6M | |
| Liabilities Current | $16.8M | $11.2M | $5.8M | $107.0K | $595.1K | $230.1K | $59.9K | |
| Liabilities And Stockholders Equity | $16.6M | $18.1M | $8.8M | $1.0M | $226.1K | $207.1K | $131.6K | |
| Assets Current | $7.0M | $7.5M | $2.0M | $14.1K | $15.8K | $207.1K | $131.6K | |
| Assets | $16.6M | $18.1M | $8.8M | $1.0M | $226.1K | $207.1K | $131.6K | |
| Cash And Cash Equivalents At Carrying Value | $426.6K | $225.6K | $2.5K | $15.7K | $19.6K | $131.6K | $126.9K | |
| Liabilities | $18.3M | $16.1M | $8.1M | $1.2M | $230.1K | $59.9K | ||
| Accounts Payable And Accrued Liabilities Current | $166.6K | $27.8K | $207.4K | $137.4K | $24.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.3M | -$3.9K | -$112.0K | |||||
| Other Liabilities Current | $981.8K | $663.8K | $235.9K | $79.2K | $387.7K | |||
| Other Assets Current | $493.5K | $2.0M | $2.0M | $11.0K | $178.00 | |||
| Debt Instrument Periodic Payment Interest | $3.9M | $3.0K | $1.8K | |||||
| Cash | $426.6K | $225.6K | $2.5K | $15.7K | $19.6K | $131.6K | $126.9K | |
| Stock Payable | $395.1K | $223.2K | $223.2K | |||||
| Receivable With Imputed Interest Value | $3.0K | $1.8K | ||||||
| Liabilities Noncurrent | $1.6M | $4.9M | $2.3M | $1.1M | ||||
| Prepaid Expense And Other Assets Current | $187.5K | |||||||
| Other Assets Noncurrent | $210.3K | |||||||
| Assets Noncurrent | $9.6M | $10.6M | $6.8M | $1.0M | ||||
| Notes And Loans Payable Current | $63.1K | |||||||
| Minority Interest | $2.3M | $1.0M | ||||||
| Inventory Net | $201.2K | $1.2M | ||||||
| Goodwill | $8.4M | $8.4M | ||||||
| Convertible Long Term Notes Payable | $2.3M | $1.1M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $201.0K | $223.1K | -$644.00 | -$12.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $1.7M | $1.3M | $966.2K | $1.9M | $1.9M | $2.5M | $38.4M | $32.9M | $28.9M | $26.1M | $20.4M | -$375.9K | -$386.6K | -$280.9K | -$143.3K | $209.0K | $12.9K | $50.6K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $971.6K | $296.7K | $360.4K | $221.6K | $101.2K | $114.5K | $5.3K | $2.4K | $2.8K | $1.2M | $1.1M | $15.7K | $5.3K | $29.7K | $11.6K | ||||||
| Common Stock Value | $169.1K | $163.9K | $140.4K | $119.7K | $133.0K | $128.0K | $126.9K | $114.6K | $102.9K | $102.9K | $100.9K | $100.3K | $92.8K | $91.0K | $91.0K | ||||||
| Retained Earnings Accumulated Deficit | -$19.1M | -$18.8M | -$18.6M | -$16.8M | -$16.3M | -$16.4M | -$5.8M | -$5.8M | -$8.4M | -$11.0M | -$12.7M | -$12.9M | -$12.6M | -$8.0M | -$7.8M | ||||||
| Liabilities Current | $15.8M | $13.9M | $12.6M | $10.1M | $8.6M | $7.2M | $150.3M | $143.6M | $141.8M | $33.2M | $120.6K | $392.1K | $580.1K | $499.3K | $344.3K | ||||||
| Liabilities And Stockholders Equity | $20.0M | $18.8M | $18.3M | $17.1M | $16.5M | $17.2M | $216.2M | $205.2M | $200.0M | $38.4M | $23.4K | $16.2K | $193.5K | $218.5K | $200.9K | ||||||
| Assets Current | $8.6M | $7.9M | $7.6M | $6.3M | $5.9M | $7.2M | $127.6M | $116.7M | $110.2M | $37.4M | $23.4K | $16.2K | $6.0K | $31.0K | $13.4K | ||||||
| Assets | $20.0M | $18.8M | $18.3M | $17.1M | $16.5M | $17.2M | $216.2M | $205.2M | $200.0M | $38.4M | $23.4K | $16.2K | $193.5K | $218.5K | $200.9K | ||||||
| Cash And Cash Equivalents At Carrying Value | $971.6K | $296.7K | $360.4K | $221.6K | $101.2K | $114.5K | $2.5K | $2.4K | $2.8K | $5.3K | $29.7K | $11.6K | $64.0K | $89.0K | $98.0K | ||||||
| Liabilities | $18.3M | $17.5M | $17.3M | $15.1M | $14.6M | $14.8M | $177.8M | $172.3M | $171.1M | $120.6K | $392.1K | $595.1K | $580.1K | $499.3K | $344.3K | ||||||
| Accounts Payable And Accrued Liabilities Current | $50.2M | $43.3M | $38.9M | $33.1M | $15.8K | $9.3K | $192.4K | $161.6K | $131.6K | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$453.2K | $477.9K | -$82.7K | $50.9K | -$1.2K | -$1.4K | -$7.9K | ||||||||||||||
| Other Liabilities Current | $1.4M | $2.2M | $2.0M | $549.6K | $410.1K | $6.3M | $81.0M | $81.4M | $102.9M | $94.6K | |||||||||||
| Other Assets Current | $2.0M | $2.0M | $2.0M | $2.0M | $2.0M | $2.5M | $7.3M | $4.9M | $109.0M | ||||||||||||
| Debt Instrument Periodic Payment Interest | $1.0M | $971.4K | -$409.8K | $745.00 | $745.00 | ||||||||||||||||
| Cash | $971.6K | $296.7K | $360.4K | $221.6K | $101.2K | $114.5K | $2.5K | $2.4K | $2.8K | $5.3K | $29.7K | $11.6K | $64.0K | $89.0K | $98.0K | ||||||
| Stock Payable | $395.1K | $395.1K | $395.1K | $395.1K | $395.1K | $360.7K | $326.4K | $292.0K | |||||||||||||
| Receivable With Imputed Interest Value | $753.00 | $745.00 | $761.00 | $754.00 | $745.00 | $762.00 | $240.00 | ||||||||||||||
| Liabilities Noncurrent | $2.5M | $3.6M | $4.7M | $5.0M | $6.0M | $7.6M | $27.5M | $28.6M | $29.3M | $1.1M | |||||||||||
| Prepaid Expense And Other Assets Current | $665.9K | $552.0K | $551.6K | $2.4M | $37.4M | $9.0K | $1.9K | $178.00 | $711.00 | $1.2K | $1.8K | ||||||||||
| Other Assets Noncurrent | $88.5M | $89.8M | $89.1M | $1.0M | $187.5K | $187.5K | $187.5K | ||||||||||||||
| Assets Noncurrent | $11.4M | $10.9M | $10.7M | $10.7M | $10.6M | $10.0M | $88.6M | $88.5M | |||||||||||||
| Notes And Loans Payable Current | $45.2K | $53.1K | $63.1K | $63.1K | $63.1K | $63.1K | |||||||||||||||
| Minority Interest | $2.1M | $1.5M | $1.2M | $730.7K | $560.5K | $1.5M | $26.9M | $24.7M | $23.8M | ||||||||||||
| Inventory Net | $921.8K | $941.4K | $1.1M | $1.1M | $1.1M | $1.4M | $1.4M | $1.5M | $1.2M | ||||||||||||
| Goodwill | $8.4M | $8.4M | $8.4M | $8.5M | $8.5M | $8.4M | $56.4M | $56.4M | |||||||||||||
| Convertible Long Term Notes Payable | $2.5M | $2.3M | $2.1M | $1.3M | $1.1M | ||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $134.8K | $112.0K | -$292.00 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$2.6M | $1.2M | $2.4M | -$415.1K | -$409.2K | -$173.1K | -$81.8K |
| Net Cash Provided By Used In Financing Activities | $4.2M | -$926.1K | $3.1M | $1.4M | $405.3K | $61.1K | $86.5K |
| Increase Decrease In Accounts Payable | $1.3M | $138.8K | -$179.6K | $70.0K | $113.4K | $14.0K | |
| Proceeds From Issuance Of Common Stock | $40.0K | $30.0K | $2.0M | $278.9K | $110.3K | $4.3K | $87.9K |
| Share Based Compensation | $2.2M | $4.7M | $1.9M | ||||
| Net Cash Provided By Used In Investing Activities | -$1.4M | -$5.6K | -$5.5M | -$1.0M | |||
| Proceeds From Related Party Debt | $4.4M | $1.9K | $1.9K | $16.0K | |||
| Increase Decrease In Other Current Liabilities | -$78.8K | $90.0K | $5.4M | -$13.5K | |||
| Increase Decrease In Other Current Assets | $46.8K | $2.3M | $10.8K | -$19.9K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $23.0K | $187.5K | |||||
| Proceeds From Repayments Of Related Party Debt | -$8.2K | -$173.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$334.8K | -$170.9K | $2.1M | $1.8M | -$180.8K | $793.2K | -$140.3K | -$54.2K | -$127.9K | -$34.5K |
| Net Cash Provided By Used In Financing Activities | $669.6K | $171.1K | -$1.8M | -$2.0M | $180.5K | -$487.3K | $139.1K | $52.8K | $120.0K | $868.00 |
| Increase Decrease In Accounts Payable | -$423.0K | $711.00 | $1.8M | $797.5K | $16.0M | $0.00 | -$5.8K | -$12.5K | ||
| Proceeds From Issuance Of Common Stock | $228.9K | $49.5K | $2.0M | $1.6K | $200.0K | $196.3K | $57.8K | $868.00 | ||
| Share Based Compensation | $1.5M | $721.0K | $68.8K | |||||||
| Net Cash Provided By Used In Investing Activities | -$200.0K | $111.8K | -$798.7K | $625.3K | -$704.1K | -$255.0K | ||||
| Proceeds From Related Party Debt | $862.2K | $1.9K | ||||||||
| Increase Decrease In Other Current Liabilities | $1.1M | $51.8K | $113.9K | -$2.9M | $59.5K | -$198.1K | ||||
| Increase Decrease In Other Current Assets | $12.8K | $980.7K | -$6.0M | $189.7K | -$321.0K | -$18.6M | $208.6K | |||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$208.6K | $1.8K | ||||||||
| Proceeds From Repayments Of Related Party Debt | -$1.9K | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.03 | $0.00 | -$0.04 | $0.00 | -$0.05 | -$0.02 | -$0.03 |
| Weighted Average Number Of Shares Outstanding Basic | 157.4M | 128.6M | 114.7M | 100.7M | 95.1M | 104.7M | 100.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 179.1M | 126.6M | 127.1M | 102.9M | 94.7M | 105.0M | 104.4M |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |
| Common Stock Shares Issued | 179.1M | 126.6M | 127.1M | 105.0M | 104.4M | ||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Earnings Per Share Basic | $-0.03 | $0.00 | $-0.04 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | $0.00 | $0.00 | -$0.01 | $0.00 | $0.00 | $0.00 | -$0.02 | -$0.01 | $0.00 | $0.00 | $0.02 | $0.02 | $0.00 | $0.00 | -$0.05 | $0.00 | $0.00 | $0.00 | -$0.01 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 167.6M | 153.4M | 135.5M | 132.8M | 130.2M | 127.8M | 118.3M | 110.2M | 102.8M | 102.9M | 102.3M | 100.6M | 107.0M | 95.1M | 91.4M | 104.7M | 104.7M | 105.0M | 104.6M | 104.4M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 169.1M | 163.9M | 140.4M | 119.7M | 133.0M | 127.1M | 126.9M | 114.6M | 102.9M | 102.9M | 100.9M | 100.3M | 92.8M | 91.0M | 91.0M | ||||||
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | |||||
| Common Stock Shares Issued | 169.1M | 163.9M | 140.4M | 119.7M | 133.0M | 127.1M | 126.9M | 114.6M | 102.9M | 102.9M | 100.9M | 100.3M | 94.7M | 92.8M | 91.0M | 91.0M | |||||
| Preferred Stock Shares Authorized | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | ||||
| Preferred Stock Shares Outstanding | 20.0K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Issued | 20.0K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||
| Earnings Per Share Basic | $0.00 | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 | $-0.02 | $-0.01 | $0.00 | $0.02 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Professional Fees | $226.3K | $849.9K | $315.0K | $294.7K | $4.8M | $1.9M | $72.6K |
| Other Expenses | -$4.1M | -$4.5K | $7.1K | $2.8M | |||
| Additional Paid In Capital | $18.5M | $18.0M | $17.3M | $12.2M | $11.9M | $7.2M | $5.4M |
| Stock Issued During Period Value New Issues | $40.0K | $30.0K | $2.0M | $57.8K | $4.3K | $87.9K | |
| Stock Issued During Period Value Other | $82.6K | $110.2K | $4.3K | $237.4K | |||
| Stock Issued During Period Value Issued For Services | $45.6K | $722.7K | $4.7M | $1.9M | |||
| Stock Issued During Period Value Conversion Of Convertible Securities | $461.1K | $387.2K | $16.5K | $2.6M | |||
| Due To Related Parties Current | $29.6K | $35.9K | |||||
| Stock Issued During Period Shares New Issues | 6.4M | ||||||
| Income Loss Including Portion Attributable To Noncontrolling Interest | -$4.4M | $423.1K | -$4.2M | ||||
| Repayments Of Lines Of Credit | $295.0K | $295.0K | |||||
| Depreciation | $171.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Professional Fees | $62.1K | $20.3K | $51.8K | $205.8K | $34.2K | $48.4K | $130.7K | $82.0K | $30.4K | $37.3K | $70.9K | $146.9K | $84.3K | $131.1K | $109.3K | $132.4K | $1.5M | $20.8K | ||||||
| Other Expenses | $25.4K | $1.4M | -$1.8M | -$990.9K | -$3.2M | $420.2K | -$408.8K | -$14.4K | -$1.1K | -$1.1K | $1.1K | $1.1K | $813.00 | $5.2K | ||||||||||
| Additional Paid In Capital | $18.5M | $18.4M | $18.3M | $17.9M | $17.5M | $17.3M | $17.2M | $13.6M | $12.2M | $12.2M | $12.1M | $12.1M | $11.8M | $7.3M | $7.2M | |||||||||
| Stock Issued During Period Value New Issues | $40.0K | $49.5K | $2.0M | $104.6K | $9.1K | $10.1K | $63.5K | $5.2K | ||||||||||||||||
| Stock Issued During Period Value Other | $913.1K | $82.6K | $38.7K | $57.8K | $20.0K | -$1.00 | $345.5K | $3.4K | $237.4K | |||||||||||||||
| Stock Issued During Period Value Issued For Services | $31.0K | $13.1K | $126.0K | $722.7K | $104.6K | $4.5M | $83.9K | $68.8K | $1.5M | |||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $23.0K | $209.1K | $228.9K | $118.9K | $25.0K | $49.5K | -$1.00 | |||||||||||||||||
| Due To Related Parties Current | $30.0K | $29.6K | $0.00 | $29.6K | $29.6K | $29.6K | ||||||||||||||||||
| Stock Issued During Period Shares New Issues | 5.5K | 4.9K | 68.7K | 8.5K | ||||||||||||||||||||
| Income Loss Including Portion Attributable To Noncontrolling Interest | -$40.2K | $156.5K | -$1.2M | -$303.8K | $372.1K | $206.7K | -$1.9M | |||||||||||||||||
| Repayments Of Lines Of Credit | $1.8M | $5.0K | $120.0K | |||||||||||||||||||||
| Depreciation | $19.7K | $429.00 | $0.00 | $653.0K | $171.0K | $565.2K | $565.0K |
Most recent annual filing with the SEC: March 31, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.